1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in Japan, October 2018 (p4)

Biotechnology Analysis & Statistics in Japan, October 2018 (p4)

91-120 of about 300 reports

NanoCarrier Co Ltd (4571) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NanoCarrier Co Ltd (4571) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryNanoCarrier Co Ltd (NanoCarrier) is a drug development company that develops and produces pharmaceuticals using micellar nanoparticles technology.The company’s pipeline products include NC-6004, ...

  • Industries : Drug Delivery, Pharmaceutical, Industrial Biotechnology, Therapy, Cancer
  • Countries : Japan
Sandoz International GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sandoz International GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummarySandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products.The company provides biosimilars, generic antibiotics, dermatology ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : World, United States, Japan
Athersys Inc (ATHX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Athersys Inc (ATHX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryAthersys Inc (Athersys) is a biotechnology company that discovers and develops of novel and proprietary best-in-class therapies in the field of regenerative medicine.Its lead platform, MultiStem, ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Chronic Disease, Pharmaceutical
  • Countries : Japan
Histogenics Corp (HSGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Histogenics Corp (HSGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryHistogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders.The company provides product such as neocart, a ...

  • Industries : Medical Biotechnology, Pharmaceutical
  • Countries : United States, Japan
Blincyto

Blincyto

  • $ 10000
  • Industry report
  • October 2018

Drug OverviewBlincyto (blinatumomab; Amgen/AstraZeneca/Astellas), produced in Chinese hamster ovary cells, is a bispecific T-cell engager that directs T-cells to target CD19-positive benign and malignant ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Cancer
  • Countries : United States, Japan, European Union
polatuzumab vedotin

polatuzumab vedotin

  • $ 10000
  • Industry report
  • October 2018

Drug OverviewPolatuzumab vedotin (Roche) is an antibody-drug conjugate (ADC) that combines a humanized immunoglobulin (Ig)-G1 monoclonal antibody (MAb) targeting human B-cell surface antigen cluster of ...

  • Industries : Therapy, Medical Biotechnology, Oncology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, European Union
2018 Japan Molecular Diagnostics and NAT Market Shares and Sales Segment Forecasts

2018 Japan Molecular Diagnostics and NAT Market Shares and Sales Segment Forecasts

  • $ 950
  • Industry report
  • October 2018

This report provides:Five-year sales forecasts for the Japanese Molecular Diagnostics market, including:                    -  Infectious Diseases             -  Canc ...

  • Industries : Pathology
  • Countries : Japan
2018 Global Molecular Diagnostics and DNA Sequencing Market Country Shares and Sales Segment Forecasts, Laboratory Universe

2018 Global Molecular Diagnostics and DNA Sequencing Market Country Shares and Sales Segment Forecasts, Laboratory Universe

  • $ 950
  • Industry report
  • October 2018

This report provides:Estimates of facilities performing DNA sequencing and molecular diagnostic testing in France, Germany, Italy, Japan, Spain, UK and USA.Five-year test volume and sales forecasts by ...

  • Industries : Genomics Proteomics and Enabling Technology, Biotechnology
  • Countries : World, France, Germany, Italy, Japan, Spain, United Kingdom, United States
2018 Japan Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application

2018 Japan Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application

  • $ 450
  • Industry report
  • October 2018

This report provides an overview of the Japanese molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.Table of ContentsBusiness Environment  ...

  • Industries : Diagnostics
  • Countries : Japan
Japan Dental Devices Market Outlook to 2025 - Dental CAD/CAM Systems and Materials, Crown and Bridge Materials, Dental Equipment, Dental Hygiene Devices, and Others

Japan Dental Devices Market Outlook to 2025 - Dental CAD/CAM Systems and Materials, Crown and Bridge Materials, Dental Equipment, Dental Hygiene Devices, and Others

  • $ 5995
  • Industry report
  • October 2018

Japan Dental Devices Market Outlook to 2025 - Dental CAD/CAM Systems and Materials, Crown and Bridge Materials, Dental Equipment, Dental Hygiene Devices, and OthersSummaryGlobalData’s new report, Japan ...

  • Industries : Medical Device, Healthcare
  • Countries : Japan, East Asia
Kyoto University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kyoto University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2018

SummaryKyoto University (Kyoto) is a research university that offers educational services.The university provides multi disciplinary courses to students of Japan including medicine, engineering, law, letters, ...

  • Industries : Pharmaceutical
  • Countries : Japan
Cedar Pollen Allergy - Pipeline Review, H2 2018

Cedar Pollen Allergy - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • September 2018

Cedar Pollen Allergy - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Cedar Pollen Allergy - Pipeline Review, H2 2018, provides an ...

  • Industries : Therapy, Chronic Disease, Pharmaceutical, Pathology, Medical Biotechnology
  • Countries : Japan, World
Japan Dental Bone Graft Procedures Outlook to 2025

Japan Dental Bone Graft Procedures Outlook to 2025

  • $ 2995
  • Industry report
  • September 2018

Japan Dental Bone Graft Procedures Outlook to 2025SummaryGlobalData’s new report, Japan Dental Bone Graft Procedures Outlook to 2025, provides key procedures data on the Japan Dental Bone Graft Procedures. ...

  • Industries : Biomaterial
  • Countries : Japan
Japan Dental Bone Graft Substitutes & Other Biomaterials Market Outlook to 2025

Japan Dental Bone Graft Substitutes & Other Biomaterials Market Outlook to 2025

  • $ 4995
  • Industry report
  • September 2018

Japan Dental Bone Graft Substitutes & Other Biomaterials Market Outlook to 2025SummaryGlobalData’s new report, Japan Dental Bone Graft Substitutes & Other Biomaterials Market Outlook to 2025, provides ...

  • Industries : Biomaterial, Industrial Biotechnology
  • Countries : Japan
Japan Dental Membrane Procedures Outlook to 2025

Japan Dental Membrane Procedures Outlook to 2025

  • $ 2995
  • Industry report
  • September 2018

Japan Dental Membrane Procedures Outlook to 2025SummaryGlobalData’s new report, Japan Dental Membrane Procedures Outlook to 2025, provides key procedures data on the Japan Dental Membrane Procedures. ...

  • Industries : Biomaterial
  • Countries : Japan
Portrazza

Portrazza

  • $ 10000
  • Industry report
  • August 2018

Drug OverviewPortrazza (necitumumab; Eli Lilly) is a recombinant IgG1 monoclonal antibody (MAb) that blocks the binding of epidermal growth factor receptor (EGFR) to its ligands. This binding prevents ...

  • Industries : Therapy, Medical Biotechnology, Oncology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, European Union
2018 Global Adenovirus Diagnostic Testing Market: US, Europe, Japan--Supplier Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

2018 Global Adenovirus Diagnostic Testing Market: US, Europe, Japan--Supplier Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

  • $ 2800
  • Industry report
  • August 2018

The report presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology ...

  • Industries : Medical Biotechnology, Diagnostics, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Europe, Japan, World, France, Germany, Italy, Spain, United Kingdom
Eiken Chemical Co Ltd (4549) - Product Pipeline Analysis, 2018 Update

Eiken Chemical Co Ltd (4549) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • August 2018

SummaryEiken Chemical Co Ltd (Eiken Chemical), a subsidiary of Hitachi High-Technologies Corp is a medical equipment provider that offers molecular genetic products and medical devices.The company manufactures ...

  • Industries : Pathology, Diagnostics, Healthcare
  • Countries : Japan, United Kingdom
Hologic: USA, Europe, Japan--Sales, Market Shares and Competitive Position by Product

Hologic: USA, Europe, Japan--Sales, Market Shares and Competitive Position by Product

  • $ 2500
  • Industry report
  • August 2018

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product ...

  • Industries : Diagnostics
  • Countries : United States, Japan, France, Germany, Italy, Spain, United Kingdom
Pomalyst

Pomalyst

  • $ 10000
  • Industry report
  • August 2018

Drug OverviewPomalyst (pomalidomide; Celgene) is an oral class I thalidomide analog, immunomodulatory drug with antineoplastic activity. In vitro studies have shown that the drug acts through multiple ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, European Union
Isatuximab

Isatuximab

  • $ 10000
  • Industry report
  • August 2018

Drug OverviewIsatuximab (Sanofi/ImmunoGen) is a humanized monoclonal antibody which targets cancer cells expressing the transmembrane glycoprotein CD38, which is highly expressed on malignant multiple ...

  • Industries : Medical Biotechnology, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, European Union
Thalomid

Thalomid

  • $ 10000
  • Industry report
  • August 2018

Drug OverviewThalomid (Celgene) contains thalidomide, a glutamic acid derivative that possesses immunomodulatory, anti-inflammatory, and anti-angiogenic properties. The drug’s mechanism of action is ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, European Union
Empliciti

Empliciti

  • $ 10000
  • Industry report
  • August 2018

Drug OverviewEmpliciti (elotuzumab; Bristol-Myers Squibb/AbbVie) is a monoclonal antibody that targets the signaling lymphocytic activation molecule family, member 7 (SLAMF7), also called CS1. This cell-surface ...

  • Industries : Medical Biotechnology, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, European Union
Dental Bone Graft Substitutes and Other Biomaterials Market, Japan, 2018-2024, MedSuite

Dental Bone Graft Substitutes and Other Biomaterials Market, Japan, 2018-2024, MedSuite

  • $ 8995
  • Industry report
  • August 2018

The dental bone grafting market has fared far better than the dental barrier membrane market in Japan. In 2017, the DBGS market was nearly eight times the size of the dental barrier membrane market. Often, ...

  • Industries : Industrial Biotechnology, Biomaterial
  • Countries : Japan
Alofisel

Alofisel

  • $ 10000
  • Industry report
  • August 2018

DRUG OVERVIEWAlofisel (darvadstrocel; TiGenix/Takeda) is a suspension of allogeneic expanded adipose-derived stem cells via intralesional injection. The therapy is being developed in Crohn’s disease ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Therapy
  • Countries : United States, Japan, European Union
Risankizumab

Risankizumab

  • $ 10000
  • Industry report
  • August 2018

Drug OverviewRisankizumab (AbbVie/Boehringer Ingelheim) is a humanized anti-interleukin (IL)-23 subunit p19 monoclonal antibody that binds and neutralizes the p19 subunit of IL-23. It is being developed ...

  • Industries : Medical Biotechnology, Pathology, Biopharmaceutical, Biopharmaceutical
  • Countries : Japan, European Union
Entyvio

Entyvio

  • $ 10000
  • Industry report
  • August 2018

Drug OverviewEntyvio (vedolizumab; Takeda) is a monoclonal antibody approved for the treatment of Crohn’s disease. It inhibits the alpha-4-beta-7 integrin receptor, preventing the migration of T cells ...

  • Industries : Medical Biotechnology, Pathology, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, European Union
Global Biosensors Industry

Global Biosensors Industry

  • $ 5600
  • Industry report
  • August 2018

This report analyzes the worldwide markets for Biosensors in US$ Thousand by the following Product Applications: Medical Biosensors (Glucose Biosensors, & Other Medical Biosensors), Environmental Biosensors, ...

  • Industries : Chronic Disease, Industrial Biotechnology, Pathology, Software
  • Countries : APAC, World, Japan, United States, Europe
Valneva SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Valneva SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2018

Valneva SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Valneva SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...

  • Industries : Pharmaceutical, Therapy, Medical Biotechnology
  • Countries : France, Japan
Ulcerative Colitis: Global Drug Forecast and Market Analysis to 2026

Ulcerative Colitis: Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • Industry report
  • June 2018

Ulcerative Colitis: Global Drug Forecast and Market Analysis to 2026SummaryThe current Ulcerative Colitis (UC) market is overcrowded with cheap generic drugs for mild to moderate disease, as well as expensive ...

  • Industries : Medical Biotechnology, Therapy, Pharmaceutical, Biopharmaceutical, Biopharmaceutical, Pathology, Healthcare
  • Countries : United States, World, Japan, North America

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on